Watch AWHL. Know when insiders buy.
One email the day a filing lands. Free.
AWHL
Aspira Women's Health Inc.
0.30
+0.00 +0.00%
USD · close Sep 8
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
51
WATCH · shorts 51
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $14MP/E —DIV YIELD —FCF YIELD —REV TTM $170K −103.9%NET INCOME −$10MNET DEBT $683K52W 0.26 – 0.65SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $17K | −89.9% | 6652.9% | −$1.8M | −$2.4M | — | -0.05 | −$2M | — | — | Aug 14 |
| Q1 2026 · Mar 31 | $32K | — | 3346.9% | −$2.2M | $676K | — | -0.05 | −$359K | — | — | Aug 14 |
| Q4 2025 · Dec 31derived | $32K | — | 4493.8% | −$1.3M | −$3.4M | — | -0.07 | −$2M | $8K | −$2M | Apr 1 |
| Q3 2025 · Sep 30 | $89K | −96.1% | 1553.9% | −$1.6M | −$4.9M | — | -0.13 | −$212K | — | — | Nov 14 |
| Q2 2025 · Jun 30 | $169K | −93.0% | 907.7% | −$1.8M | −$2.7M | — | -0.07 | −$1.7M | — | — | Aug 14 |
| Q1 2025 · Mar 31 | $0 | −100.0% | — | −$3.2M | −$1.9M | — | -0.09 | −$3.1M | — | — | Aug 14 |
| Q4 2024 · Dec 31derived | −$6.8M | −108.5% | -21.8% | −$3.4M | −$1.4M | — | -0.05 | −$1M | $0 | −$1M | Apr 1 |
| Q3 2024 · Sep 30 | $2.3M | +1.8% | 60.0% | −$3.7M | −$3.5M | — | -0.23 | −$2.9M | $2K | −$2.9M | Nov 14 |
| Q2 2024 · Jun 30 | $2.4M | — | 58.6% | −$4.4M | −$3.5M | — | -0.28 | −$3.7M | $15K | −$3.8M | Nov 14 |
| Q1 2024 · Mar 31 | $2.2M | — | 56.4% | −$4.7M | −$4.6M | — | -0.39 | −$4.4M | $20K | −$4.5M | Nov 14 |
| Q4 2023 · Dec 31derived | $80M | — | 1.5% | −$4.1M | −$3.1M | — | -0.27 | −$3.5M | $12K | −$3.5M | Mar 27 |
| Q3 2023 · Sep 30 | $2.2M | — | 59.0% | −$4.1M | −$4.7M | — | -0.48 | $3.3M | $0 | $3.3M | Nov 19 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $343K | 1724.5% | −$7.9M | −$12.8M | -3725.9% | -0.37 | −$7M | $16K | −$7M | — | — |
| FY2024 · to Dec 31 | $4K | 136975.0% | −$16.3M | −$13.1M | -327350.0% | -0.93 | −$12.1M | $37K | −$12.2M | — | — |
| FY2023 · to Dec 31 | $87M | 6.0% | −$18.9M | −$16.7M | -19.2% | -1.81 | −$15.9M | $24K | −$15.9M | — | — |
| FY2022 · to Dec 31 | $8.2M | 52.8% | −$31.1M | −$29.9M | -365.2% | -3.85 | −$31.1M | $232K | −$31.3M | — | — |
| FY2021 · to Dec 31 | $6.8M | 45.0% | −$32.6M | −$31.7M | -464.8% | -4.27 | −$27.4M | $184K | −$27.6M | — | — |
| FY2020 · to Dec 31 | $4.7M | 26.6% | −$18M | −$17.9M | -385.0% | -0.18 | −$14.7M | $490K | −$15.2M | — | — |
Every number comes from Aspira Women's Health Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.